Attorney Obligations to Disclose Pharmacy Liens to Clients

James Wong — Founder & Pharmacist, LienScripts | March 26, 2026 | 7 min read

Attorneys have specific ethical obligations to disclose pharmacy liens to PI clients — at enrollment, during the case, and at settlement. Failure to disclose creates bar grievance exposure, malpractice risk, and client dissatisfaction.

Attorney Obligations to Disclose Pharmacy Liens to Clients

Attorneys have affirmative ethical obligations to disclose pharmacy lien arrangements to personal injury clients at every stage of the case. These obligations arise from the rules of professional conduct governing client communication, candor, informed consent, and fiduciary duty. Failure to disclose pharmacy liens — their nature, their accumulating balance, and their impact on the settlement distribution — is one of the most common sources of client complaints, bar grievances, and malpractice claims in PI practice.

• Disclosure obligations begin at enrollment when the client signs the pharmacy lien authorization and continue through settlement disbursement
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages — the same transparency tools support the attorney's disclosure obligations by providing clear, client-facing balance information
• According to James Wong, PharmD, founder of LienScripts, attorneys who proactively disclose pharmacy lien balances throughout the case virtually eliminate the settlement-day complaints that lead to grievances and malpractice claims
• The duty to disclose includes explaining the lien mechanism, providing periodic balance updates, and itemizing the lien on the settlement statement
• Disclosure is not merely a best practice — it is an ethical requirement under the rules of professional conduct in every jurisdiction

The Ethical Framework

Duty to Communicate

Model Rule 1.4 (and its state equivalents) requires attorneys to:

• Promptly inform the client of any decision or circumstance requiring the client's informed consent
• Reasonably consult with the client about the means by which the client's objectives are to be pursued
• Keep the client reasonably informed about the status of the matter
• Explain a matter to the extent reasonably necessary for the client to make informed decisions

A pharmacy lien is a material financial obligation that directly affects the client's settlement recovery. The client cannot make informed decisions about their case — including whether to accept a settlement offer — without understanding the lien obligations that will be deducted.

Duty of Candor

The attorney must be truthful with the client about the pharmacy lien arrangement. This means:

• Not describing lien-based medications as "free" without clarification
• Not minimizing the expected pharmacy costs
• Not concealing the growing lien balance
• Not presenting the settlement distribution in a way that obscures the pharmacy lien deduction

Fiduciary Duty

As a fiduciary, the attorney owes the client the highest duty of loyalty and good faith. Recommending a pharmacy lien program — which benefits the client through medication access but creates a financial obligation against the settlement — requires full disclosure of the implications.

[!KEY] The pharmacy lien enrollment decision is the client's to make, with the attorney's guidance. The attorney must provide sufficient information for the client to give informed consent — including the nature of the lien, the expected cost trajectory, and the impact on their eventual settlement recovery.

Disclosure at Each Stage

At Enrollment

What to disclose:

• The pharmacy lien mechanism: medications are provided at no upfront cost, with the balance paid from settlement proceeds
• That the costs are deferred, not eliminated — the client will pay from their settlement
• An estimate of expected costs based on the injury type and anticipated treatment duration
• How the pharmacy lien fits within the overall settlement distribution (alongside attorney fees, costs, and medical liens)
• The client's right to decline the pharmacy lien arrangement
• Alternative options for medication access (insurance, out-of-pocket, patient assistance programs)

How to document:

• The pharmacy lien authorization form signed by the client
• A separate plain-language disclosure document explaining the lien in non-legal terms
• A note in the case file documenting the verbal explanation provided
• The client's signature acknowledging they understood the disclosure

During the Case

What to disclose:

• Periodic updates on the current lien balance
• Notification when new, more expensive medications are added to the regimen
• Explanation of how the lien balance compares to the estimated case value
• Updates on how the pharmacy lien balance affects the projected settlement distribution

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The LienScripts platform provides attorneys with downloadable balance summaries that can be shared directly with clients. This makes the periodic disclosure obligation easy to fulfill — the attorney simply shares the current balance report and discusses it with the client."

[!TIP] Schedule pharmacy lien balance disclosures alongside other case update communications. When you update the client on case status, include the current pharmacy lien balance. This integrates the disclosure into existing workflow rather than creating a separate task that is easy to forget.

At Settlement

What to disclose:

• The exact pharmacy lien payoff amount
• An itemized breakdown of charges
• Any negotiated reductions and the savings achieved
• The lien's position in the settlement distribution
• The client's net recovery after all deductions
• The client's right to review the itemized charges and ask questions

Settlement statement requirements:

The settlement statement must itemize the pharmacy lien as a separate line item — not buried in a general "liens" category. The client must be able to see exactly how much is being paid to the pharmacy lien holder and understand the charge.

Common Disclosure Failures

Failure 1: The "Free Medications" Misrepresentation

Describing pharmacy lien medications as "free" without qualifying that the cost is deferred creates a material misrepresentation. When the client discovers the deduction at settlement, they feel deceived — and they have a legitimate grievance.

Fix: Always describe the arrangement as "$0 upfront" or "no out-of-pocket cost during the case," followed immediately by an explanation that the cost accumulates and is paid from the settlement.

Failure 2: No Balance Updates During the Case

Some attorneys enroll the client, explain the lien at enrollment, and then provide no updates until settlement. By that time, the balance may have grown significantly, and the client has had no opportunity to make informed decisions about their treatment based on cost awareness.

Fix: Provide balance updates at least quarterly for active cases, and immediately when significant medication changes affect the balance trajectory.

Failure 3: Lump-Sum Settlement Statement

Presenting the pharmacy lien as part of a lump "medical liens" figure without itemization deprives the client of the transparency needed to evaluate the charge.

Fix: Itemize the pharmacy lien separately on the settlement statement, with the name of the pharmacy lien provider and the specific amount.

Failure 4: No Explanation of Write-Off Efforts

If the attorney negotiated a reduction, the client should know — it demonstrates advocacy. If the attorney did not negotiate when the lien was disproportionate, the client may have grounds to question the attorney's diligence.

Fix: Document and communicate all write-off negotiation efforts and outcomes to the client.

[!KEY] The disclosure obligation is not satisfied by having the client sign a form at enrollment. It is an ongoing duty that requires periodic communication throughout the case. A signed authorization form without subsequent balance updates does not protect the attorney from a grievance based on inadequate communication.

Consequences of Non-Disclosure

Bar Grievances

Clients who are surprised by pharmacy lien deductions at settlement frequently file bar complaints. These complaints allege:

• Failure to communicate material information about the case
• Failure to obtain informed consent for the lien arrangement
• Failure to provide adequate accounting of settlement funds
• Misrepresentation about the cost of medications

Malpractice Claims

In some cases, non-disclosure of pharmacy liens supports malpractice claims:

• The client argues they would have made different treatment decisions if informed of the costs
• The client argues they would have accepted an earlier, lower settlement offer if they knew the lien balance
• The client argues the attorney failed to negotiate lien reductions, resulting in reduced recovery

Client Relationship Damage

Even without formal complaints, disclosure failures damage the attorney-client relationship and the firm's reputation. Clients who feel deceived at settlement do not refer friends and family, do not leave positive reviews, and do tell their negative experience to others.

Best Practices Summary

1. Explain the lien at enrollment in plain language, with cost estimates
2. Document the explanation with a signed acknowledgment
3. Provide balance updates at least quarterly during active treatment
4. Notify clients of material changes in their lien balance
5. Present itemized settlement statements with the pharmacy lien as a separate line
6. Communicate negotiation efforts and outcomes to demonstrate advocacy
7. Give clients time to review and question the settlement distribution before disbursement

Next Steps

Pharmacy lien disclosure is an ethical obligation that protects both the client and the attorney. Firms that build disclosure into their standard workflow — rather than treating it as an afterthought — avoid the grievances, claims, and relationship damage that non-disclosure creates.

See how LienScripts supports attorney disclosure obligations — transparent pricing, real-time balance tracking, and client-facing reports that make compliance straightforward.